Holding(s) in Company

RNS Number : 8201Z
Allergy Therapeutics PLC
11 February 2014
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i
 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii


Allergy Therapeutics PLC

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights


X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):

 


 

3. Full name of person(s) subject to the notification obligation: iii


SOURTHERN FOX INVESTMENTS LTD.

4. Full name of shareholder(s)

(if different from 3.): iv

 

CHASE NOMINEES LTD - CMBLJPPB

5. Date of the transaction and date on which the threshold is crossed or reached: v

6th February, 2014

6. Date on which issuer notified:

11th February, 2014

7. Threshold(s) that is/are crossed or

reached: vi, vii


Over 24.06%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ord GBP 0.01

GB00B02LCQ05

98,332,784

98,332,784

98,632,784

98,632,784


24.06%


 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion
Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

 

% of voting
rights






 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise
price

Expiration
date
xvii

Exercise/
Conversion
period
xviii

Number of voting
rights instrument
refers to

% of voting rights xix, xx

 






Nominal

Delta

 



 

Total (A+B+C)

Number of voting rights

Percentage of voting rights


98,632,784


24.06%

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

 

 

 

Proxy Voting:

10. Name of the proxy holder:


SOURTHERN FOX INVESTMENTS LTD

 

11. Number of voting rights proxy holder will cease to hold:


12. Date on which proxy holder will cease to hold voting rights:


 

13. Additional information:


14. Contact name:


George O'Carroll

15. Contact telephone number:

+353-61-472019

 



 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUAAVRSOAUAAR
UK 100

Latest directors dealings